PANEL: Reforms to rapidly reshape health care
Reform-induced changes dominate health care panel of health care experts convened by Indianapolis Business Journal.
Health Care
Articles
Health care law definition of ‘affordable’ vague
Researchers at IU and Cornell say that how the federal government defines "affordable" could leave millions of dependents of low and moderate income workers without reasonably priced insurance.
Medical supplier Hill-Rom makes $42M fraud settlement
Hill-Rom Holdings Inc., a medical-equipment company based in Indiana, agreed Tuesday to pay nearly $42 million to settle a government lawsuit. The government had accused the company of knowingly submitting false claims to Medicare from 1999 to 2007.
Accountable care ‘savior’ of doc groups
Indianapolis’ largest independent physician group, American Health Network, doesn’t want to sell to a hospital, but its CEO hopes it can hold on until accountable care kicks in.
Q&A
Dr. Ed Kowlowitz, owner and medical director of the Center for Pain Management in Indianapolis, recently challenged a regional Medicare reimbursement policy and, surprisingly, won. He spoke with IBJ about the experience, as well how his three-physician practice is growing even while many physician practices are selling to hospitals.
Firm tries again with personal health records
Even though Google Inc. has given up on the business of electronic personal health records, Fort Wayne-based NoMoreClipboard.com is launching a new service it thinks will crack open the market.
Wishard to use $8.3M grant to stem substance abuse
At three community health centers, all patients will be asked about their alcohol and drug usage confidentially, as part of an early-intervention approach designed to cut down addictions and reduce hospitalization.
Carmel-based company buys medical-billing firm
Zotec Partners, a fast-growing physician-billing management company based in Carmel, has acquired a family-owned medical-billing firm with 100 employees based in Florida.
Debate rages over whether Lilly’s Byetta lifts cancer risk
A German researcher disputed the validity of a study that found Byetta and another diabetes drug increase cancer risk.
IU Cancer Center recruits top researcher
Dr. Murray Korc, an internationally known pancreatic cancer researcher, comes to the cancer center as the first Myles Brand Professor of Cancer Research. The position is funded through a Lilly Endowment grant.
Survey: Workers’ health care costs rose in high single digits
Benefit consultant Nyhart says the typical Hoosier is paying $105 per month for single coverage and $417 per month for family coverage.
Health regulatory leaders ready to flock to city
The top event for regulatory professionals in the health care industry is headed to Indianapolis next month. The annual conference of the Regulatory Affairs Professionals Society, or RAPS, is expected to draw thousands of members representing 120 companies and organizations.
Lilly invests $30M in chronic-disease partnerships
Drugmaker Eli Lilly and Co. said Tuesday it will spend $30 million over five years to fight chronic illnesses like heart disease, diabetes, cancer and respiratory disease in developing countries.
FDA gets new report on Lilly diabetes drug
Drugmakers Eli Lilly and Co. and Amylin Pharmaceuticals Inc. said Monday that patients taking their potential once-weekly diabetes treatment, Bydureon, saw a significant improvement in cardiovascular risk factors.
IBM putting Watson to work in health insurance
IBM’s supercomputer system, best known for trouncing the world’s best “Jeopardy!” players on TV, is being tapped by one of the nation’s largest health insurers to help diagnose medical problems and authorize treatments.
Gloomy outlook for medical device makers
The next four years could be rough for makers of medical devices and orthopedic implants, including Bloomington-based Cook Medical Inc. and Warsaw-based Zimmer Holding Inc. and Biomet Inc.—and not because of the 2010 health reform law.
Study spoils common wisdom on health spending
The Thomson Reuters study that showed Anderson as the highest-spending health care market in the nation also concluded that treatment and spending vary widely from one locale to another with no clear reason based on demographics or health outcomes.
FDA deal with drugmakers raises user fees 6 percent
Drugmakers including Eli Lilly an Co. have agreed with regulators on a 6-percent increase in review fees as part of reauthorizing the drug-approval process through fiscal 2017.
Indiana company quits Missouri Medicaid contract
Indianapolis-based SynCare has ended its contract to screen Missouri Medicaid recipients after numerous complaints about its job performance.
Private firm with Medicaid deal gets state help
Officials with the Missouri Department of Health and Senior Services say they had to hire 13 temporary workers and shift as many as 20 state workers from their regular jobs after withering consumer complaints against SynCare LLC of Indiana.